Moderna and the US Government approached a secret agreement, right as China began mobilizing in preparation for the forthcoming coronavirus pandemic.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
“In May 2019, NIH and Moderna entered into a ‘research collaboration agreement’ to develop vaccine candidates against the Middle East Respiratory Syndrome coronavirus (MERS-CoV) and Nipah virus,” a Public Citizen investigation notes. “The project was focused on evaluating candidates in animal models. NIH signed an amendment to the document on January 13, 2020—the day the agency and Moderna finalized the design of their novel coronavirus vaccine. The amendment is significantly redacted and does not mention the new coronavirus. However, the close proximity suggests the terms of the contract may have been expanded to apply to this new project. At the very least, the terms may have been instructive for the mRNA-1273 project.”
The NIH-Moderna secret agreement was in close proximity to another event: China’s initial mobilizations for a coming coronavirus pandemic in May 2019.
“Purchases of PCR tests in China’s Hubei Province surged months before the first official reports of a novel coronavirus case there, according to a report by Australia-based cybersecurity company Internet 2.0,” Nikkei Asia reported. “About 67.4 million yuan ($10.5 million at current rates) was spent on PCR tests in Hubei during 2019, nearly double the 2018 total, with the upswing starting in May, according to the report.”
“The report casts further doubt on China’s official line about the origins of the virus, a topic that has fueled tensions between Beijing and Washington,” Nikkei Asia added. “China’s foreign ministry has disputed the report’s findings.”
However, the NIH and Moderna had been working together for at least four years on an mRNA drug for coronaviruses. It was only in May 2019 that the confidential agreement was entered into.
“The National Institutes of Health may own intellectual property that undergirds a leading coronavirus vaccine being developed by Moderna, according to documents obtained by Axios and an analysis from Public Citizen,” the June 2020 Axios report said.
“Why it matters: Because the federal government has an actual stake in this vaccine, it could try to make the vaccine a free or low-cost public good with wide distribution, if the product turns out to be safe and effective,” the report added.